Package 51316-567-01

Brand: olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 51316-567-01
Digits Only 5131656701
Product NDC 51316-567
Product ID 51316-567_3fe3c75e-cb1f-bb27-8b6e-6f34dee09a0e
Description

1 BOTTLE in 1 CARTON (51316-567-01) / 2.5 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2026-01-15
Brand olopatadine hydrochloride ophthalmic solution
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "3fe3c75e-cb1f-bb27-8b6e-6f34dee09a0e", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1601086"], "spl_set_id": ["56d56cb8-b04c-5f48-b0c3-5639a79fd2c5"], "manufacturer_name": ["CVS Pharmacy"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (51316-567-01)  / 2.5 mL in 1 BOTTLE", "package_ndc": "51316-567-01", "marketing_start_date": "20260115"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "51316-567_3fe3c75e-cb1f-bb27-8b6e-6f34dee09a0e", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "51316-567", "generic_name": "olopatadine hydrochloride ophthalmic", "labeler_name": "CVS Pharmacy", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "7 mg/mL"}], "application_number": "ANDA213514", "marketing_category": "ANDA", "marketing_start_date": "20260115", "listing_expiration_date": "20261231"}